Table 5 Results of the multivariate logistic model analysis evaluating the probability of being treated with adjuvant chemotherapy for pT1a and pT1b breast cancers
From: Adjuvant chemotherapy of pT1a and pT1b breast carcinoma: results from the NEMESI study
Variable | Odds ratio | 95% CI | P value |
|---|---|---|---|
Age range (years) | 0.0185 | ||
≥70 | 1 | ||
18–34 | NE | NE | |
35–49 | 8.22 | 2.00-33.67 | |
50–70 | 2.44 | 0.69-8.58 | |
Grading | 0.024 | ||
G1 | 1 | ||
G2 | 3.48 | 0.56-5.01 | |
G3 | 8.33 | 1.82-33 | |
ER receptor | 0.0007 | ||
Positive | 1 | ||
Negative | 11.43 | 2.78-47.03 | |
Proliferative index | 0.001 | ||
Low | 1 | ||
Medium | 2.08 | 0.28-16 | |
High | 9.10 | 2.57-33 | |
HER2 | 0.002 | ||
Negative | 1 | ||
Positive | 9.09 | 2.73-33.3 |